ORKA Stock: Price, Earnings History and SEC Filings
Oruka Therapeutics, Inc. (ORKA) last traded at $96.87, up 0.23% on the latest session and up 16.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.55 against an analyst estimate of $-0.49, a miss of 12.2%.
$96.87 +0.23%
1 month+16.30%
52-week high$115.52
52-week low$25.23
Volume634,040
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ORKA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 10, 2026 | $-0.55 | $-0.49 | -12.24% |
| Mar 2026 | May 13, 2026 | $-0.48 | $-0.52 | +7.69% |
| Dec 2025 | Mar 12, 2026 | $-0.45 | $-0.61 | +26.23% |
| Sep 2025 | Nov 12, 2025 | $-0.55 | $-0.56 | +1.79% |
ORKA beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ORKA
SEC filing data is not available right now. You can search for ORKA on SEC EDGAR.
ORKA news
- Oruka Therapeutics Stock Gets A Lift From Psoriasis Trial ResultsOct 27, 2026 · finance.yahoo.com
- Oruka Therapeutics Reports Strong Phase 2b Psoriasis ResultsOct 27, 2026 · theglobeandmail.com
- Oruka’s ORKA-001 Delivers 61% Complete Skin Clearance in Phase IIb Psoriasis StudyOct 27, 2026 · marketbeat.com
- Oruka Therapeutics Soars 12% as Psoriasis Drug Clears Skin in 61% of High-Dose Patients: “A Paradigm Shift”Oct 26, 2026 · tikr.com
- Oruka’s Psoriasis Treatment Could Generate $7B In Peak Sales, Says Guggenheim – ORKA Stock Heads For Best Day In Over 4 MonthsOct 26, 2026 · stocktwits.com
- Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe PsoriasisOct 26, 2026 · finance.yahoo.com
- Stocktwits Pharma Pulse: Big Pharma Earnings, Cancer Updates And 2 FDA Deadlines — The Week’s Biotech WatchlistOct 26, 2026 · stocktwits.com
- Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026Oct 25, 2026 · finance.yahoo.com
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. (ORKA) is a US-listed public company on Nasdaq.